Ischaemia-reperfusion time differences in ST-elevation myocardial infarction in very young patients: a cohort study

Pablo Juan-Salvadores1,2, Luis Mariano De La Torre Fonseca3, Beatriz Calderon-Cruz4

  • 1Cardiology, Hospital Alvaro Cunqueiro, Vigo, Spain pablo.juan.salvadores@sergas.es marianotorre33@gmail.com.

Open Heart
|January 28, 2025
PubMed

Insights

Young patients with ST-elevation myocardial infarction (STEMI) receive faster diagnoses. However, healthcare delays are linked to major adverse cardiac events (MACE) and reduced survival in all STEMI patients.

Area of Science:

  • Cardiology
  • Emergency Medicine

Background:

  • ST-elevation myocardial infarction (STEMI) is a common presentation in younger individuals.
  • Timely medical intervention is critical for improving patient prognosis in STEMI cases.

Purpose of the Study:

  • To compare ischemia-reperfusion times between STEMI patients aged ≤40 and >40 years.
  • To investigate the association of these times with long-term mortality and major adverse cardiac events (MACE).

Main Methods:

  • A retrospective, multicenter cohort study involving 6799 STEMI patients.
  • Patients were divided into two groups: ≤40 years and >40 years.
  • Analysis focused on diagnosis times, delay factors, and MACE occurrence.

Main Results:

  • Younger STEMI patients achieved earlier electrocardiographic diagnoses.
  • Delays in diagnosis were associated with female sex, dyspnea, and non-hemodynamic hospital presentations.
  • Healthcare delays were identified as a risk factor for MACE within the first year.

Conclusions:

  • Younger STEMI patients generally receive quicker diagnoses compared to older counterparts.
  • Delays in healthcare are a significant factor contributing to MACE and poorer survival rates in STEMI patients.
Abstract